Blog
Drug Target Encyclopedia Series (33) —NCR2
Release Time：
2026-03-17 13:58
NCR2, also known as NKp44, is a natural cytotoxicity receptor mainly expressed on activated NK cells. As a key membrane protein in innate immunity, NCR2 supports tumor recognition, NK-cell activation, and cytokine release.
In immuno-oncology, NCR2 is gaining attention as a promising target for NK-cell engager design, CAR-NK engineering, and next-generation cell therapy development.
Why NCR2 matters
• Highly relevant to NK-cell–mediated tumor surveillance
• Linked to anti-tumor cytotoxicity and immune activation
• Valuable for cell therapy, antibody discovery, and immune profiling
Emerging strategies around NCR2
• CAR-NK and engineered NK platforms
• Ligand discovery and receptor biology studies
• mRNA-based tools for target validation and transient expression research
Key challenge
How to translate NCR2 biology into stronger and more durable anti-tumor responses in complex tumor microenvironments.
Industry takeaway
As NK-cell therapeutics continue to expand, NCR2 is becoming an increasingly important target in innate immunity–focused drug discovery.
Need NCR2 tools for your research?
Fill out the form below, or visit the link: to browse the complete list of available in-stock products.
E-mail：support@levostar.com
USA
16192 Coastal Hwy，Lewes, DE 19958
TEL：619-537-9202
China
A3-502 No.328, Xinghu Street, Suzhou Industrial Park, Suzhou, Jiangsu, China 215123
TEL：0512-62888898